F2R and prostate carcinoma: PAR-1, the prototypic member of the PAR family, has been identified as an oncogene and has been reported to promote cancer invasion and metastasis in the context of multiple cancers, including breast, colon, lung, pancreatic and prostate cancer as well as melanoma [14, 31–35].